A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Amgen Inc stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 5,098 shares of AMGN stock, worth $1.63 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,098
Previous 5,098 -0.0%
Holding current value
$1.63 Million
Previous $1.59 Million 3.14%
% of portfolio
0.18%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$262.75 - $319.31 $11,561 - $14,049
44 Added 0.87%
5,098 $1.59 Million
Q4 2023

Feb 05, 2024

SELL
$255.7 - $288.46 $3,835 - $4,326
-15 Reduced 0.3%
5,054 $1.46 Million
Q2 2023

Jul 27, 2023

BUY
$214.27 - $253.37 $26,355 - $31,164
123 Added 2.49%
5,069 $1.13 Million
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $9,343 - $10,365
-40 Reduced 0.8%
4,946 $1.21 Million
Q1 2021

May 11, 2021

BUY
$221.91 - $258.6 $8,876 - $10,344
40 Added 0.81%
4,986 $1.24 Million
Q2 2020

Aug 05, 2020

SELL
$197.81 - $242.74 $989 - $1,213
-5 Reduced 0.1%
4,946 $1.17 Million
Q1 2020

May 06, 2020

SELL
$182.24 - $241.7 $1,275 - $1,691
-7 Reduced 0.14%
4,951 $1 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $42,572 - $54,720
-225 Reduced 4.34%
4,958 $1.2 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $1,218 - $1,460
7 Added 0.14%
5,183 $1 Million
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $743,571 - $867,986
4,168 Added 413.49%
5,176 $1.01 Million
Q4 2018

Feb 11, 2019

SELL
$178.4 - $208.25 $752,491 - $878,398
-4,218 Reduced 80.71%
1,008 $1.01 Million
Q3 2018

Nov 07, 2018

SELL
$185.29 - $208.89 $14,823 - $16,711
-80 Reduced 1.51%
5,226 $1.08 Million
Q1 2018

May 07, 2018

SELL
$169.43 - $198.0 $4,235 - $4,950
-25 Reduced 0.47%
5,306 $904,000
Q4 2017

Feb 12, 2018

BUY
$168.79 - $188.59 $131,656 - $147,100
780 Added 17.14%
5,331 $927,000
Q2 2017

Aug 11, 2017

BUY
N/A
4,551
4,551 $784,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Folger Nolan Fleming Douglas Capital Management, Inc Portfolio

Follow Folger Nolan Fleming Douglas Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Folger Nolan Fleming Douglas Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Folger Nolan Fleming Douglas Capital Management, Inc with notifications on news.